Healthcare & Life Sciences
Amylon Therapeutics
Netherlandsamylon.com/
Amylon Therapeutics is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Seed, 1 tracked investor.
activeseed
seed
Stage
1
Investors
About Amylon Therapeutics
Amylon Therapeutics is a startup based in the Netherlands. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Amylon Therapeutics develops therapies for central nervous system disorders, with a focus on rare genetic diseases, using RNA modulation technology to treat conditions such as Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch type (HCHWA-D).
Explore Amylon Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.